DGX Chart

1 Month

	Date	Diff
	2023-03-20	+1.05 %
Quest Diagnostics (NYSE: DGX) stock went up by 1.05% as the company announced the completion of its acquisition of select assets of Northern Light Laboratory, which is expected to enable physicians and patients throughout Maine to benefit from access to Quest's industry-leading and highly innovative test menu, network of patient access sites, broad health plan coverage, and lower out-of-pocket costs for many services.
	2023-03-16	+0.87 %
Quest Diagnostics' (DGX) stock went up 0.87% last night as healthcare company, UiPath, announced that Quest Diagnostics selected their Document Understanding technology over other competitors to help them analyze and process millions of documents, as part of their strategy to expand their automation program. Quest Diagnostics' stock went up by 0.87% after executives discussed priorities to grow revenues and create shareholder value, which includes initiatives to drive growth, with expectations to generate mid single-digit CAGR in revenues and high single-digit CAGR in adjusted EPS from 2023 through 2026. The article discusses Quest Diagnostics' path for growth, focusing on delivering a superior customer experience at a lower cost and continuing to deliver productivity savings, and does not provide a clear reason for why the stock went up 0.87% last night. Quest Diagnostics (DGX) stock went up 0.87% last night as it expects to gain a strong position in the growing genomics and oncology market through advancements in next-generation sequencing (NGS) and leveraging digital pathology and artificial intelligence (AI). Quest Diagnostics (DGX) stock went up by 0.87% after the company updated its long-term financial outlook during its Investor Day, stating that it expects to generate mid single-digit CAGR revenues and high single-digit CAGR adjusted EPS for the period between 2023 and 2026 with initiatives underway to drive growth and enhance operational productivity.
	2023-03-10	-0.43 %
Agilent Technologies has announced an end-to-end solution for digital pathology, bringing together various products, vendors, and partners to drive efficiency, patient care, clinical utility, and quality control, identifying opportunities in precision medicine and companion diagnostics.
	2023-03-07	-1.86 %
Quest Diagnostics' stock has gone down due to a 48% drop in COVID-19 testing revenue to $1.5 billion, but the company is not dependent on COVID-19 tests for its revenue and is likely to return to growth in 2024 and beyond with new non-COVID tests launching, and the company's forward price-to-earnings ratio is far below the diagnostics and research industry's average of 22.9, making it an interesting pick for dividend growth investors.
	2023-03-02	+0.51 %
Quest Diagnostics (DGX) stock went up 0.51% after the company mentioned during their earnings call that they have begun using a highly automated microbiology lab system that leverages AI to analyze samples.
	2023-02-16	+0.03 %
Quest Diagnostics provides diagnostic information services that enhance the quality and value of diagnostic services to patients and their doctors.
	2023-02-15	+1.4 %
Quest Diagnostics Incorporated (DGX) posted better-than-expected results last week, sending its stock up 7.6%. The company expects growth in its core business segments, as well as increased reinvestment into growth. The stock is priced reasonably at 18x trailing earnings, with a potential for even greater returns in the future. The company has just announced a 7% increase in their dividend, which is good news for dividend stock holders.
	2023-02-13	+1.02 %
Quest Diagnostics(DGX) is a provider of diagnostic information services. Quest Diagnostics creates diagnostic information that helps people take action to improve their health outcomes. Quest Diagnostics is a provider of diagnostic information services. Their investor day will be held on March 16, 2023 and they will provide updates on the U.S. laboratory market, their business strategy, capital deployment priorities, and long-term outlook.
	2023-02-06	+1.81 %
On January 9, 2023, Global Hemp Group Inc. executed a consulting contract with Dr. Stephen D. Barnhill, MD, to join the GHG team as Special Medical Advisor. Dr. Barnhill is Chairman & CEO of Apollon Formularies, Plc and a Medical Doctor specializing in Cannabinoid and Mycomedicinal Therapeutics, Drug Discovery and Artificial Intelligence. The Company is excited to have Dr. Barnhill on board and his experience and insight will be invaluable as the GHG looks to begin an IP sub-licensing program of its recently acquired exclusive North American licensing of Apollon
	2023-02-02	-2.13 %
Quest Diagnostics Inc. (QDG) shares lowered Wednesday as investors weighed concerns about the strength of the company's outlook in the face of continued rate hikes by the central bank. Quest Diagnostics, Inc. stocks decline because the company reports lower-than-expected earnings. Quest Diagnostics (DGX) stock goes down because the company has announced that it is increasing its dividend and increasing its share repurchase authorization.
	2023-02-01	+0.11 %
Quest Diagnostics is one of the most admired companies in the world, and their diagnostic insights can help improve people's health.
	2023-01-30	+0.09 %
Quest Diagnostics Inc. is a biopharmaceutical company that provides diagnostic tests and services to health care providers.
	2023-01-23	+1.09 %
Quest diagnostics(DGX) stock is going up because the company is making progress in its cancer detection tests. Quest Diagnostics releases the results of the first annual "Know Your Health" survey which indicates that more Americans know their horoscope sign and credit score than their blood type or cholesterol level. Agilent and Quest have partnered to make the ctDx FIRST liquid biopsy test widely available to the U.S. population. This will expand the testing options available for NSCLC patients and is likely to result in improved patient outcomes. According to Wall Street analysts, Quest Diagnostics is expected to report better-than-forecast earnings for the third quarter of 2018. This news is likely to cause the stock price to go up.
	2023-01-20	+0.09 %
Quest Diagnostics(DGX) releases fourth quarter and full year 2022 financial results on February 2, 2023.
	2023-01-19	+0.14 %
Quest Diagnostics is a leading laboratory services provider and its stock prices are expected to rise in the near future as the global pandemic slowly eases and the population tests for COVID less often.
	2023-01-17	-0.26 %
Quest Diagnostics (DGX) stock goes down because the company revealed plans to nearly double the space of its headquarter facilities in Birmingham and add at least 200 full-time employee positions based on economic development incentives from the state of Alabama.
	2023-01-13	-0.12 %
Quest Diagnostics Corporation is a medical technology company that provides products and services in the fields of oncology, hematology, infectious disease, and immunology.
	2023-01-11	+0.2 %
Quest Diagnostics Incorporated is a leading provider of diagnostic information services that serve hospitals and physicians throughout the United States. This stock goes up when the company delivers positive news.
	2022-12-08	+1.01 %
the world's leading provider of diagnostic information services
	2022-12-06	+0.03 %
The stock's rise snapped a two-day losing streak
	2022-11-17	-2.22 %
risks to business growth and increasing cost headwinds
	2022-10-31	-0.65 %
reduction in Covid-related income
	2022-10-20	+6.32 %
Since the stock has returned a solid 49% to shareholders reporting earnings that beat Wall Street expectations
	2022-10-10	+0.58 %
The stock's rise snapped a three-day losing streak